ライフサイエンスコーパス: fibrocyte

1 l proliferation once they differentiate into fibrocytes.

2 is known about signaling from fibroblasts to fibrocytes.

3 to the enhanced basal migratory motility of fibrocytes.

4 (SAP), and healthy tissues contain very few fibrocytes.

5 asons, very few monocytes differentiate into fibrocytes.

6 tive myofibroblasts, and bone marrow-derived fibrocytes.

7 ferentiate into fibroblast-like cells called fibrocytes.

8 (+)) showed selective expression of CD206 on fibrocytes.

9 raction of cockroach allergens with CD206 in fibrocytes.

10 otein kinase (p38), ERK, and JNK in cultured fibrocytes.

11 monocytes into fibroblast-like cells called fibrocytes.

12 h levels of functional CD40 are displayed by fibrocytes.

13 XCL2 upregulation in the rat spiral ligament fibrocytes.

14 ionine are incorporated into Tg expressed by fibrocytes.

15 s substantial activity when transfected into fibrocytes.

16 markedly increased CD34(+)/procollagen 1(+) fibrocytes.

17 migration of bone marrow-derived circulating fibrocytes.

18 i polarization and generation of circulating fibrocytes.

19 ne marrow-derived mesenchymal stem cells and fibrocytes.

20 oplastic collagen- and fibronectin-producing fibrocytes.

21 diseases is associated with monocyte-derived fibrocytes.

22 d 2.78 +/- 0.36-fold compared with Ccr5(-/-) fibrocytes (1.0 +/- 0.06; p < 0.05).

23 ress syndrome patients to differentiate into fibrocytes; 2) the influence of the acute respiratory di

24 d fibrosing diseases is the monocyte-derived fibrocyte, a collagen-secreting profibrotic cell.

25 tients with Graves' disease (GD), as well as fibrocyte abundance, were determined by flow cytometry.

26 Bone marrow-derived fibrocytes accumulate in the dermis.

27 characterized the role of CTGF in promoting fibrocyte accumulation and regulation after AngII exposu

28 Pulmonary fibrocyte accumulation is also decreased by inhibitor tr

29 omal ERalpha to FSP1+, CD34+, SMA- precursor fibrocytes adjacent to normal and precancerous CIN epith

30 from stromal keratocytes and from BM-derived fibrocytes after epithelial-stromal and endothelial-stro

31 Monocyte-derived cells called fibrocytes also activate fibroblasts, and we found that

32 We now report that fibrocytes also express Tg, which resolves as a 305-kDa

33 Injection of WT enhanced GFP(+) fibrocytes also increased the number of Gr-1(Int), CD11b

34 WT and Ccl2(-/-) fibrocytes also stimulated Ccl2 expression in the lung b

35 sis, and arise from bone marrow (BM)-derived fibrocytes and a variety of local progenitor cells.

36 exicanin I increased the number of MDSCs and fibrocytes and accelerated the wound healing.

37 Levels of CD206 expression on human fibrocytes and CD206 mediated signaling and cytokine pro

38 OF and dampens the inflammatory phenotype of fibrocytes and CD34(+) OF.

39 ng flow cytometry, we quantified circulating fibrocytes and characterized their chemokine receptor ex

40 The functional properties of fibrocytes and dermal fibroblasts were tested by using r

41 uced the expression of CTGF and alpha-SMA in fibrocytes and fibrocyte differentiation in patients wit

42 Previously, leukocyte progenitors termed fibrocytes and myofibroblasts generated from epithelial

43 CD40 levels on cultivated fibrocytes and orbital fibroblasts (GOFB) from patients

44 EAV has specific tropism for stromal cells (fibrocytes and possibly tissue macrophages) and CD8(+) T

45 was observed between CD45(+)Col1(+)CXCR4(+) fibrocytes and the activation phenotypes CD45(+)Col1(+)p

46 r ability of monocytes to differentiate into fibrocytes and the inhibitory effect of the alveolar env

47 Bone marrow-derived fibrocytes and the monocyte chemoattractant protein-1 in

48 ading to reduction in the number of cultured fibrocytes and total nonadherent non-T cells from health

49 talline basophils deposits of minerals, rare fibrocytes and very few vessels brought in discussion a

50 found two populations: (i) CD45(+) CD34(+) (fibrocytes) and (ii) CD45(+) CD34(-) [myeloid-derived su

51 ells, CD45(+) CD34(+) collagen I(+) CXCR4(+) fibrocytes, and HSP47(+) activated fibroblasts that were

52 decision of monocytes to differentiate into fibrocytes, and indicate that modulating lumican signali

53 decision of monocytes to differentiate into fibrocytes, and may indicate that modulating Slit2 signa

54 monocytes into fibroblast-like cells called fibrocytes, and promotes phagocytosis of cell debris by

55 mesenchymal cells, attraction of circulating fibrocytes, and stimulation of the epithelial to mesench

56 ulted in decreased accumulation of MDSCs and fibrocytes, and wound healing was significantly delayed.

57 Fibrocytes are bone marrow-derived circulating progenito

58 Fibrocytes are circulating bone marrow-derived cells tha

59 Fibrocytes are circulating progenitor cells that are inc

60 Fibrocytes are circulating, hematopoietic cells that exp

61 Fibrocytes are detectable in bronchoalveolar lavage duri

62 Circulating CD40(+)CD45(+)Col1(+) fibrocytes are far more frequent in vivo in donors with

63 Fibrocytes are hematopoietic stem cell-derived fibroblas

64 Fibrocytes are hematopoietic-derived cells with mesenchy

65 These data may explain why fibrocytes are increased in fibrotic tissues, suggest th

66 Fibrocytes are mesenchymal progenitors involved in norma

67 Fibrocytes are monocyte-derived fibroblast like cells th

68 Alveolar fibrocytes are monocyte-derived mesenchymal cells associ

69 mice injured with bleomycin indicating that fibrocytes are not a necessary source of type I collagen

70 ese findings demonstrate that high levels of fibrocytes are present in the peripheral blood of patien

71 These data may explain why fibrocytes are rarely observed in healthy tissues, may s

72 Blood fibrocytes are recruited during COPD exacerbations and r

73 kines to recruit these fibrocytes or whether fibrocytes are stimulated to home to the affected tissue

74 at the inner ear fibrocytes (spiral ligament fibrocytes) are able to recognize nontypeable Haemophilu

75 Fibroblast progenitor cells (fibrocytes) are important to the development of myocardi

76 compared to control subjects nor were blood fibrocytes associated with lung function or qCT, but wer

77 ignificantly increased number of circulating fibrocytes at V1 compared with control subjects.

78 The percentage of fibrocytes at V2 was negatively correlated with FEV1, fo

79 r the phenotypic and functional hallmarks of fibrocytes but mediate immune suppression.

80 , GLAST was expressed in the spiral ligament fibrocytes but was not detected in the satellite cells o

81 ferentiate into fibroblast-like cells called fibrocytes, but fibrocyte differentiation is strongly in

82 Peripheral blood fibrocytes can accelerate wound healing by stimulating c

83 luorescence-activated cell sorting analysis, fibrocytes (CD45(+) and collagen 1 [Col1](+)) were enume

84 Flow cytometric analyses of human fibrocytes (CD45(+) and collagen-1(+)) showed selective

85 Fibrocytes (CD45+/collagen 1+) were quantified in bronch

86 [myeloid-derived suppressor cell (MDSC)-like fibrocytes] cells in stable COPD (n = 41) and control (n

87 Here we quantify CD40 expression on fibrocytes, circulating, and bone marrow-derived progeni

88 A few fibrocytes-circulating and bone marrow-derived mesenchym

89 om neighboring cells account for much of the fibrocyte collagen.

90 Fibrocytes collected from patients with COPD at V1 had i

91 fold increased ability to differentiate into fibrocytes compared to ventilated controls or non-ventil

92 CXCR4(+) fibrocyte concentration may be useful as a biomarker for

93 nd final values of peripheral blood CXCR4(+) fibrocyte concentration were strongly associated with de

94 a cross-sectional analysis, peripheral blood fibrocyte concentrations were markedly elevated in a sub

95 These data support our hypothesis that fibrocytes contribute to premetastatic conditioning by r

96 llectively, our data suggest that neoplastic fibrocytes contribute to the induction of BM fibrosis in

97 ion and activation state of peripheral blood fibrocytes correlates with asthma severity.

98 We measured circulating fibrocyte counts and chemokine levels in a cohort of sub

99 nd marked episodic elevations in circulating fibrocyte counts over a median follow-up period of 614 d

100 The number of circulating fibrocytes decreased at V2.

101 thout (n = 11) COPD was collected for tissue fibrocyte detection.

102 Furthermore, WT fibrocytes did not increase Ly-6C(+) monocytes in Ccr2(-

103 at aa Q55 and E126 in human SAP affect human fibrocyte differentiation and SAP binding to FcgammaRI.

104 that tryptase and thrombin potentiate human fibrocyte differentiation at biologically relevant conce

105 n the concentration of SAP needed to inhibit fibrocyte differentiation by 95%.

106 veolar lavage fluid inhibited by 71% (55-94) fibrocyte differentiation compared to saline control.

107 ent in mice, similar to PGE(2) that inhibits fibrocyte differentiation from blood of healthy donors a

108 vital for CTGF expression, which results in fibrocyte differentiation in COA, and suggests that an E

109 sion of CTGF and alpha-SMA in fibrocytes and fibrocyte differentiation in patients with COA.

110 Lumican competes with the serum fibrocyte differentiation inhibitor serum amyloid P, but

111 proliferation in the myocardium and enhances fibrocyte differentiation into a myofibroblast phenotype

112 fibroblast-like cells called fibrocytes, but fibrocyte differentiation is strongly inhibited by the p

113 NaCl-increased fibrocyte differentiation may thus contribute to NaCl-in

114 However, the mechanism of fibrocyte differentiation remains unclear.

115 nitial trigger to override SAP inhibition of fibrocyte differentiation to initiate scar tissue format

116 uction of BM fibrosis in PMF, and inhibiting fibrocyte differentiation with SAP may interfere with th

117 P binds to FcgammaRI on monocytes to inhibit fibrocyte differentiation, and binds to FcgammaRIIa on n

118 combinant LGALS3BP inhibits monocyte-derived fibrocyte differentiation, and immunodepletion of LGALS3

119 an IgG-blocking Ab reduces the SAP effect on fibrocyte differentiation, and ligating FcgammaRIIa with

120 rotein called serum amyloid P (SAP) inhibits fibrocyte differentiation, and sialidases attenuate SAP

121 ocytes, and unlike other factors that affect fibrocyte differentiation, lumican has no detectable eff

122 In vitro studies, including fibrocyte differentiation, regulation of 15-PGDH, RT-PCR

123 ctivity that inhibits human monocyte-derived fibrocyte differentiation, whereas less aggressive breas

124 nditioned media removes the monocyte-derived fibrocyte differentiation-inhibiting activity.

125 rum and SAP that normally completely inhibit fibrocyte differentiation.

126 ng, but little is known about what initiates fibrocyte differentiation.

127 related proteoglycan decorin, promotes human fibrocyte differentiation.

128 ers of LGALS3BP, potentiate monocyte-derived fibrocyte differentiation.

129 ta2 integrins are needed for lumican-induced fibrocyte differentiation.

130 ecrete factors that inhibit monocyte-derived fibrocyte differentiation.

131 ted platelets release a factor that promotes fibrocyte differentiation.

132 polyphosphatase, and polyphosphate promotes fibrocyte differentiation.

133 protein Slit2 and that Slit2 inhibits human fibrocyte differentiation.

134 ther, our data suggest that NaCl potentiates fibrocyte differentiation.

135 lasma protein Serum Amyloid P (SAP) inhibits fibrocyte differentiation.

136 chloride and sodium nitrate also potentiate fibrocyte differentiation.

137 sts, and we found that sialidases potentiate fibrocyte differentiation.

138 oncho-alveolar lavage fluid had no effect on fibrocyte differentiation.

139 ry distress syndrome alveolar environment on fibrocyte differentiation; and 3) mediators involved in

140 ized that if these chemokines are recruiting fibrocytes, disrupting their signaling will reduce early

141 pha transgenic mouse model demonstrated that fibrocytes do not transform into WT1(+) mesenchymal cell

142 tudy demonstrate a novel association between fibrocyte-driven WT1(+) cell accumulation and severe fib

143 A high percentage of circulating fibrocytes during exacerbation was associated with incre

144 nstrated that two circulating populations of fibrocyte exist in COPD, with distinct clinical associat

145 The degree of fibrocyte expansion observed in individual subjects dire

146 These findings indicate that human fibrocytes express multiple "thyroid-specific" proteins,

147 Fibrocytes express several chemokine receptors (CCR7 and

148 ing collagen-promoter GFP mice, we find that fibrocytes express type I collagen.

149 ound that CD34(+) progenitor cells, known as fibrocytes, express functional TSHR, infiltrate the orbi

150 To do so, we isolated fibrocytes expressing CD45, CD11b, CD13, and Col1a1 from

151 herent non-T (NANT) cells were isolated, and fibrocytes expressing CD45, collagen I, CTGF, ETAR, or a

152 The blood concentration of fibrocytes expressing the chemokine receptor CXCR4 corre

153 Fibrocyte expression of both proinflammatory and profibr

154 Fibrocyte expression of collagens and profibrotic growth

155 ferentially expressed chemokines (i) promote fibrocyte (FC) migration towards ASM and (ii) are increa

156 nters and augment immune reactivity, whereas fibrocytes from cancer subjects suppressed anti-CD3-medi

157 Intriguingly, collagen-producing fibrocytes from hematopoietic lineages were observed att

158 Circulating fibrocytes from nonadherent non-T-cell mononuclear cell

159 ated alpha-SMA expression induced by ET-1 in fibrocytes from normal participants.

160 0A9 enhances the basal migratory motility of fibrocytes from patients in the Asthma AE group and pati

161 Expression of EGFR was increased in fibrocytes from patients with COA compared with that see

162 Fibrocytes from patients with COA have a greater capacit

163 After being cultured, CTGF was increased in fibrocytes from patients with COA, but not from those of

164 ronchial walls and overexpression of CTGF in fibrocytes from patients with COA.

165 Dexamethasone reduced CCR7 expression in fibrocytes from patients with nonsevere asthma but not f

166 ticoid receptor expression was attenuated in fibrocytes from patients with severe asthma.

167 In cocultures, fibrocytes from the mdx(5cv) diaphragm stimulated a high

168 bits the differentiation of monocyte-derived fibrocytes from wild-type mouse spleen cells, but not fr

169 In the injured liver, fibrocytes gave rise to (myo)fibroblasts.

170 Unlike fibrocytes, GD orbital fibroblasts, which comprise a mix

171 Fibrocytes gradually lose their hematopoietic cell marke

172 Fibrocytes have been considered to play a role in allerg

173 pulmonary cell types and bone marrow-derived fibrocytes have been implicated as contributors to fibro

174 Fibrocytes have been proposed as an important direct con

175 onocyte-derived fibroblast-like cells called fibrocytes help to form scar tissue.

176 Fibrocytes highly expressed CXCR4 and CCR3, the chemokin

177 Blood MDSC-like fibrocytes, however, are increased and associated with p

178 ntibody, M22, robustly induce IL-23 in human fibrocytes; however, IL-12 expression is essentially und

179 marker, supports the blood-borne circulating fibrocyte hypothesis of the disease.

180 erized the function of CD45(+)/collagen I(+) fibrocytes in acutely injured skeletal muscle of wild-ty

181 We showed the accumulation of fibrocytes in bronchial walls and overexpression of CTGF

182 The aims of this study were: 1) to quantify fibrocytes in bronchoalveolar lavage fluid from patients

183 The role of fibrocytes in chronic obstructive pulmonary disease (COP

184 increased number of activated/differentiated fibrocytes in circulating blood of asthmatic patients ex

185 We sought to enumerate blood and tissue fibrocytes in COPD and determine the association of bloo

186 suggesting roles for TLR7/8 in induction of fibrocytes in HCV infection.

187 uated by flow cytometry, and the presence of fibrocytes in HP and normal lungs by confocal microscopy

188 There were higher numbers of circulating fibrocytes in patients in the Asthma AE group and patien

189 CR4/CXCL12 axis contributes to chemotaxis of fibrocytes in patients in the Asthma AE group, whereas t

190 FR) activation mediated the proliferation of fibrocytes in patients with COA and whether oxidative st

191 udy was to evaluate the recruitment of blood fibrocytes in patients with COPD during exacerbations an

192 We propose that fibrocytes in severe asthma are different from those in

193 primary auditory neurons, and, finally, the fibrocytes in the lateral wall.

194 The presence of fibrocytes in the lung during acute respiratory distress

195 ar SP-D regulates numbers of macrophages and fibrocytes in the lungs, profibrotic cytokine expression

196 WT but not Ccr5(-/-) fibrocytes increased the number of metastatic foci when

197 In co-cultures, fibrocytes induced on lung fibroblasts a significant inc

198 Likewise, fibrocytes induced the up-regulation of CCL2 in HP lymph

199 d AngII + AMD3100 animals showed exacerbated fibrocyte infiltration and fibrosis compared with AngII

200 ng their signaling will reduce early (3-day) fibrocyte infiltration and, consequently, fibrosis in th

201 Treatment of the xenograft mice with the fibrocyte inhibitor serum amyloid P (SAP; pentraxin-2) s

202 , but dominates over the fibroblast-secreted fibrocyte inhibitor Slit2.

203 Basal CD40 expression on fibrocytes is greater than that on GOFB.

204 The frequency of circulating CD40(+) fibrocytes is markedly increased in patients with TAO, s

205 Fibrocytes isolated from BLM-treated iSP-D mice off Dox

206 The conditioned medium from fibrocyte-like cells (FcCM) has been shown to stimulate

207 Thus, alterations in the ability of IUGR fibrocyte-like cells to stimulate angiogenesis may contr

208 decrease the ability of both normal and IUGR fibrocyte-like cells to stimulate angiogenesis.

209 in the angiogenic zones of the placenta are fibrocyte-like cells.

210 Desmoid tumors also contained a subclass of fibrocytes linked to wound healing, angiogenesis, and fi

211 ssion increase in the skin, in tandem with a fibrocyte marker, supports the blood-borne circulating f

212 Fibrocytes may participate in the pathogenesis of HP, am

213 The application of fibrocytes may represent a potential clinical solution f

214 The mesenchymal progenitors, fibrocytes, may be involved in the remodeling of asthmat

215 It has been proposed that circulating fibrocytes mediate the disease.

216 The cell markers are consistent with fibrocytes mediating the disease.

217 Bone marrow-derived fibrocytes migrate to injured tissues and contribute to

218 Fibrocytes migrated towards recombinant CCL2 and ASM sup

219 Early CTGF expression occurred before fibrocyte migration (1 day) into the myocardium or ECM d

220 , respectively, by 50% and 25% inhibition of fibrocyte migration in Col-Luc(CCR2-/-)-->wt and Col-Luc

221 4, a chemokine receptor that is important in fibrocyte migration into the lungs.

222 Plerixafor, a CXCR4 antagonist, decreased fibrocyte migration to plasma from patients with exacerb

223 e role of the chemokines CXCL12 and CCL11 in fibrocyte migration was investigated by using a chemotax

224 Our findings suggest that i.m. fibrocytes most likely originate from infiltrating monoc

225 ion of bone marrow-derived progenitor cells (fibrocytes) occurs before deposition of extracellular ma

226 upregulated expression of S100A9 and RAGE in fibrocytes of patients in the Asthma AE group and those

227 posed of smooth muscle cells and surrounding fibrocytes of the tunica adventitia and the lamina propr

228 The effect of fibrocytes on lung fibroblasts and T lymphocytes was exa

229 lso noted the presence of collagen-producing fibrocytes on the epicardial surface that resulted at le

230 s (6 hours), well before the accumulation of fibrocytes or TGF-beta mRNA up-regulation.

231 organs liberate chemokines to recruit these fibrocytes or whether fibrocytes are stimulated to home

232 A bronchoalveolar lavage fibrocyte percentage >6% provides an additive prognostic

233 everity of illness, a bronchoalveolar lavage fibrocyte percentage >6% was independently associated wi

234 Comparison of bronchoalveolar lavage fibrocyte percentage from patients with or without acute

235 Addition of bronchoalveolar lavage fibrocyte percentage in a clinical model predicting mort

236 e prognostic value of bronchoalveolar lavage fibrocyte percentage in patients with acute lung injury

237 Therefore, we sought to determine whether fibrocytes play a role in the induction of BM fibrosis i

238 We examined circulating fibrocyte populations for correlations with clinical par

239 nce involves continuous viral replication in fibrocytes (possibly including tissue macrophages) and T

240 Fibrocyte potentiation by thrombin and tryptase is media

241 In this report, we demonstrate that fibrocytes predispose the lung to B16-F10 metastasis by

242 rs also report that TSLP is able to activate fibrocytes, probably by inducing stromal cell-derived fa

243 Fibrocytes produce high levels of cytokines, including i

244 F on isolated fibrocytes suggested a role in fibrocyte proliferation (twofold; P < 0.05) and collagen

245 inhibitors of EGFR tyrosine kinase, reduced fibrocyte proliferation and myofibroblast transformation

246 Enhanced fibrocyte proliferation and transformation found in pati

247 Increased expression of EGFR and fibrocyte proliferation and transformation were induced

248 In addition, CTGF contributes to fibrocyte proliferation in the myocardium and enhances f

249 Although fibrocytes promote collagen production by fibroblasts, l

250 In TAO, CD34(+) fibrocytes, putatively derived from bone marrow, can be

251 The CXCL12/CXCR4 axis is involved in such fibrocyte recruitment (Firebrob study; ClinicalTrials NC

252 In conclusion, early fibrocyte recruitment cannot be inhibited through modula

253 The CXCL12/CXCR4 axis is involved in such fibrocyte recruitment.

254 of smooth muscle precursors and adventitial fibrocytes, respectively, by E13.5.

255 we show that fibroblasts stimulated with the fibrocyte-secreted inflammatory signal tumor necrosis fa

256 However, classical fibrocytes serve as antigen presenters and augment immun

257 activation of granulocytes, proliferation of fibrocytes/smooth muscle cells, and basement membrane th

258 sly, we have demonstrated that the inner ear fibrocytes (spiral ligament fibrocytes) are able to reco

259 There was correlation between circulating fibrocyte subsets and asthma severity, and there was an

260 metastatic risk to conditions that mobilize fibrocytes, such as inflammation and wound repair.

261 The effect of CTGF on isolated fibrocytes suggested a role in fibrocyte proliferation (

262 ional cockroach allergen-CD206 axis in human fibrocytes, suggesting a role for CD206 in regulating al

263 asthma have elevated numbers of circulating fibrocytes that show enhanced myofibroblastic differenti

264 Like classical fibrocytes, they display cell surface alpha smooth muscl

265 reports regarding the direct contribution of fibrocytes to collagen deposition.

266 The shift from IL-23p19 expression in fibrocytes to that of IL-12p35 in their derivative CD34(

267 As of now, fibrocyte trafficking has yet to be demonstrated.

268 ts (RAGE; ie, its receptor), are involved in fibrocyte trafficking in patients with chronic obstructi

269 CXCL12/CXCR4 and CCL19/CCR7 enhanced fibrocyte transmigration in the Asthma AE group and in p

270 on of CCL19 in bronchial tissues and CCR7 in fibrocytes was higher in patients with COA.

271 n bronchial tissues and CXCR4 in circulating fibrocytes was higher in the Asthma AE group and, to a l

272 pression of CCR7, CXCR4, S100A9, and RAGE in fibrocytes was measured by using flow cytometry.

273 -dependent uptake of FITC labeled Bla g 2 by fibrocytes was observed, but was significantly inhibited

274 that collagen type 1 intensity for MDSC-like fibrocytes was positively associated with lung function

275 increase in total and CD45(+)Col1(+)CXCR4(+) fibrocytes was primarily seen in patients with severe as

276 Migration of CD45(+)Col(+) fibrocytes was regulated by chemokine receptors CCR2 and

277 median percentage of bronchoalveolar lavage fibrocytes was significantly higher in patients with acu

278 The percentage of circulating fibrocytes was significantly increased in patients with

279 Fibrocytes were counted at basal condition and after cul

280 Fibrocytes were detected in 90 of 92 (98%) bronchoalveol

281 Fibrocytes were detected in acutely injured muscles and

282 g and cytokine production in Bla g 2 treated fibrocytes were determined.

283 CD45(+)/CXCR4(+)/Col-I(+) circulating fibrocytes were evaluated by flow cytometry, and the pre

284 Numerous fibrocytes were found infiltrating the HP lungs near fib

285 The rat spiral ligament fibrocytes were found to release CXCL2 in response to no

286 Total and differentiating fibrocytes were identified by their expression of CD45,

287 d (alpha-smooth muscle actin [alpha-SMA](+)) fibrocytes were increased in asthmatic patients compared

288 lating alpha-SMA(+) and alpha-SMA(+)CXCR4(+) fibrocytes were increased in asthmatic patients experien

289 Myeloid-derived suppressor cell-like fibrocytes were increased in COPD compared to controls [

290 Fibrocytes were not detected in peripheral blood of WT m

291 Blood and tissue fibrocytes were not increased compared to control subjec

292 ls of ET-1 and the expression of the ETAR in fibrocytes were significantly higher in patients with CO

293 Isolated circulating fibrocytes were used for migration assay.

294 Fibrocytes, which are bone marrow-derived mesenchymal pr

295 MDSCs have been shown to differentiate into fibrocytes, which serve as emerging effector cells that

296 injury, lymphocyte subsets, and circulating fibrocytes, will be presented.

297 COPD and determine the association of blood fibrocytes with clinical features of disease.

298 However, fibrocytes with confirmed deletion of the type I collage

299 onors cultured with IL-4 differentiated into fibrocytes with the same phenotypic profile and immunosu

300 Increased numbers of circulating fibrocytes, with greater myofibroblastic differentiation